跳至主要内容
临床试验/NCT03853824
NCT03853824已完成不适用

African Surgical OutcomeS-2 (ASOS-2) Trial

University of Cape Town2 个研究点 分布在 1 个国家目标入组 27,507 人开始时间: 2019年5月6日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
27,507
试验地点
2
主要终点
In hospital mortality.

研究概览

简要总结

An international, multicentre, African cluster randomised trial.

Primary objective :

To determine whether increased postoperative surveillance in high-risk adult surgical patients reduces overall in-hospital mortality in surgical patients aged 18 years and over in Africa.

Primary outcome measure:

In-hospital mortality, censored at 30 days if the patient is still alive and in-hospital.

Secondary objective:

To determine whether increased postoperative surveillance in high-risk adult surgical patients reduces the overall incidence of the composite of severe in-hospital complications and mortality in adult surgical patients aged 18 years and over in Africa.

Secondary outcome measure:

Composite of severe in-hospital complications and mortality, censored at 30 days if the patient is still alive and in-hospital.

详细描述

Study design:

ASOS-2 is an African, international, multicentre, cluster randomised trial.

Inclusion criteria:

  • Patients: All consecutive adult patients aged 18 years and over admitted to participating centres undergoing elective and non-elective surgery
  • Participating surgical centres: Randomised according to a stratification based upon the level of the surgical facility and the surgical case load. Recruitment will start in May 2019.

Exclusion criteria:

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • All consecutive adult patients aged 18 years and over admitted to participating centres undergoing elective and non-elective surgery

排除标准

  • Prior participation in ASOS-2

结局指标

主要结局

In hospital mortality.

时间窗: In-hospital, and censored at 30 days after surgery if still in-hospital.

Number of Participants with In hospital mortality

次要结局

  • Composite of severe in-hospital complications and mortality(In-hospital, and censored at 30 days after surgery if still in-hospital.)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Bruce Biccard

Consultant Anaesthetist

University of Cape Town

研究点 (2)

Loading locations...

相似试验

African Surgical OutcomeS-2 (ASOS-2) Trial | 临床试验